The Centers for Disease Control and Prevention (CDC) is highlighting its rapid response to an unprecedented outbreak of infant botulism linked to ByHeart infant formula, a case that underscores the critical role of swift public health action. As of December 10, 2025, 51 infants across 19 states have been hospitalized and treated with BabyBIG®, an antitoxin, in connection with the outbreak, though thankfully, no deaths have been reported. This incident marks the first-ever outbreak of infant botulism associated with infant formula, prompting a nationwide alert and a collaborative effort between the CDC, the U.S. Food and Drug Administration (FDA), and state health departments.
The investigation began to accelerate in early November 2025, when the California Department of Public Health’s Infant Botulism Treatment and Prevention Program (IBTPP) alerted the CDC to a concerning increase in cases. Typically, the United States sees around 150-180 cases of infant botulism annually, but the emergence of multiple cases linked to a single product raised immediate red flags. The CDC and FDA quickly engaged with ByHeart, urging the company to capture action to remove potentially contaminated formula from the market. Parents are now strongly advised to discontinue use of any ByHeart Whole Nutrition infant formula, even if it appears to be available for purchase.
Expanding the Timeline: Cases Date Back to 2023
Initial investigations focused on recent cases, but a deeper dive into reported incidents, in collaboration with the IBTPP, revealed that the outbreak’s timeline extends further back than initially thought. CDC investigators have now expanded the outbreak date range to include 10 cases dating back to December 2023. This broadened scope emphasizes the importance of ongoing surveillance and the potential for delayed recognition in rare illnesses like infant botulism. The CDC is continuing to analyze data to determine the full extent of the contamination and identify any additional cases.
Understanding Infant Botulism and its Symptoms
Infant botulism is a rare but serious illness caused when a baby ingests Clostridium botulinum spores, which then grow in the gut and produce a dangerous toxin. According to the CDC, symptoms often begin with constipation, but are more commonly noticed as difficulty feeding – including problems with sucking and swallowing – a weak or altered cry, and diminished head control. Recognizing these early signs is crucial for prompt medical attention. BabyBIG®, short for Botulism Immune Globulin Intravenous, is the primary treatment for infant botulism, and its availability has been vital in managing this outbreak.
A Rapid Response in Action
The speed of the response in this case is being lauded as a success story for public health infrastructure. On November 7, 2025, the IBTPP notified the CDC of the concerning increase in cases. By that evening, the CDC and FDA were already in direct communication with ByHeart. The following day, November 8, the CDC issued an initial alert urging parents to stop using two specific lots of ByHeart formula. Just two days later, on November 11, the warning was expanded to encompass all ByHeart infant formula products. “While we typically expect to see 150-180 individual cases of infant botulism annually, an outbreak of infant botulism is unprecedented,” stated Dr. Jennifer Cope, chief of the Enteric Diseases Epidemiology Branch, highlighting the unusual nature of the situation.
The CDC’s laboratories are currently conducting thorough testing of clinical samples from affected infants, as well as samples of ByHeart formula collected from homes. This ongoing laboratory work is essential to pinpoint the source of the contamination and prevent future occurrences. The agency is too working closely with state and local health departments to ensure that healthcare providers are aware of the outbreak and equipped to diagnose and treat affected infants.
What Parents Should Do
The CDC continues to strongly advise parents and caregivers to immediately stop using any ByHeart Whole Nutrition infant formula. This recommendation applies even if the formula is found on store shelves or online. Laboratory tests have confirmed the presence of botulism spores in the formula, making it unsafe for infant consumption. Parents who have used ByHeart formula and are concerned about their infant’s health should contact their healthcare provider immediately. Symptoms of infant botulism, such as constipation, difficulty feeding, and a weak cry, should not be ignored.
This outbreak serves as a critical reminder of the importance of vigilant food safety practices and the demand for a robust public health system capable of responding quickly and effectively to emerging threats. The CDC’s swift action, coupled with the collaboration of state health departments and the FDA, has been instrumental in containing this outbreak and protecting the health of infants across the country.
The CDC will provide further updates as the investigation progresses. Parents and healthcare professionals can locate the latest information on the CDC’s website regarding the infant botulism outbreak linked to ByHeart infant formula.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Have questions or comments about this story? Share your thoughts below.
